Abacavir update.
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D014486:United States Food and Drug Administration; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D015507:Drugs, Investigational; D000099227:Abacavir